Physician profile
Carl E Lee
NPI 1881644847
$4,303.42
in general payments reported to CMS, 2019-2025
36 companies · $574 in 2025
The $574 reported for 2025 was more than what 83% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $662 · 2020: $342 · 2021: $729 · 2022: $673 · 2023: $815 · 2024: $509 · 2025: $574.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,799 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,799.09 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $536.36 | 2019-2023 | |
| Astellas Pharma US INC | $388.82 | 2022-2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $344.10 | 2019-2023 | |
| Abbvie INC. | $286.55 | 2019-2022 | |
| Coopersurgical, INC. | $272.50 | 2019-2024 | Advincula Delineator Uterine Manipulator, Paragard T 380a, Summit Doppler |
| Exeltis, USA INC. | $268.19 | 2019-2025 | Slynd |
| Sage Therapeutics, LLC | $192.08 | 2024-2025 | Zurzuvae |
| Medtronic, INC. | $189.65 | 2022-2025 | Truclear |
| Organon LLC | $187.78 | 2021-2025 | Nexplanon |
| Boston Scientific Corporation | $183.07 | 2021-2024 | Watchman Flx |
| Hologic Sales and Service, LLC | $174.36 | 2019-2025 | Novasure, Myosure Tissue Removal Device, Fluent Fluid Management System |
| Sumitomo Pharma America, INC. | $167.98 | 2023-2025 | Myfembree |
| Myovant Sciences INC. | $132.84 | 2021-2022 | |
| Avion Pharmaceuticals | $111.54 | 2019-2023 | Balcoltra |
| Mayne Pharma Commercial LLC | $87.05 | 2022-2023 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $79.64 | 2019-2022 | |
| Myriad Women'S Health, INC. | $76.62 | 2023 | Myrisk |
| Evofem Biosciences, INC. | $73.75 | 2022-2025 | Phexxi, Solosec, Phexx |
| Therapeuticsmd, INC. | $67.84 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $67.40 | 2019-2021 | |
| Allergan, INC. | $60.53 | 2019-2020 | |
| Millicent US INC | $55.26 | 2023-2025 | Intrarosa, Femring, Femlyv |
| Dexcom, INC. | $40.75 | 2025 | Dexcom G6 Transmitter |
| Cumberland Pharmaceuticals, INC. | $30.27 | 2024-2025 | Caldolor |
| Vertical Pharmaceuticals, LLC | $29.79 | 2019-2020 | |
| Ethicon US, LLC | $28.81 | 2024 | Stratafix, Ethicon, Dermabond Prineo |
| Supernus Pharmaceuticals, INC. | $24.26 | 2025 | Qelbree |
| Integra Lifesciences Corporation | $22.96 | 2023 | Duraseal Exact Spinal Sealant System, Cusa Clarity, Codman Certas |
| Aspira Women'S Health INC | $18.92 | 2024 | Ova1 |
| Optumhealth Care Solutions, LLC | $18.59 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Acessa Health INC. | $16.33 | 2020 | |
| Exact Sciences Corporation | $15.33 | 2025 | Cologuard Collection Kit |
| Scynexis, INC. | $14.80 | 2022 | |
| Smith+Nephew, INC. | $14.54 | 2019 | |
| Minerva Surgical, INC | $12.27 | 2019 | |
| Lupin INC. | $11.89 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carl Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.